Carve outs and Causation: Moving Away From Hypothetical Hatch-Waxman Infringement - Kluwer Patent Blog

The Hatch-Waxman Act allows the FDA to permit a generic version of a branded product, which is partially patent protected, to come to market if the generic manufacturer “carves out” the patent-protected indication from its label. The scope of...